Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Tinted Soft Scleral Eye Shields When IPL is Applied Directly on Eyelids of Subjects With Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT05168670 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.

NCT NCT05168670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05168670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Tinted Soft Scleral Eye Shields When IPL is Applied Directly on Eyelids of Subjects With Dry Eye Disease Due to Meibomian Gland Dysfunction
Lead sponsor
Lumenis Be Ltd.
Phase
Not applicable
Overall status
Completed
Start date
December 21, 2021
Completion date
January 25, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, meibomian gland dysfunction